Comparison of narrow-band imaging and conventional nasopharyngoscopy for the screening of unaffected members of families with nasopharyngeal carcinoma
Authors:
- 23 January 2013
- journal article
- research article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 270 (9) , 2515-2520
Abstract
Familial aggregation of nasopharyngeal carcinoma (NPC) has been widely reported. The excess risk is about 4–8-fold among first-degree relatives of NPC patients compared with those without a family history of the disease. We used nasopharyngoscopy and a narrow-band image system (NBI) to screen NPC high-risk patients and identify a good tool for the early detection of NPC in these high-risk groups. We recruited all available, affected blood relations of the patients. When NPC patients were more distant relatives, such as cousins, we recruited their shared second-degree relatives, such as unaffected aunts and uncles, to genetically connect the NPC cases. We performed transnasal endoscopy, first in white-light mode, then under the NBI system. There were two NBI patterns in NPC: microvascular proliferation and engorged blood vessels. The NBI pattern in normal nasopharyngeal mucosa was a regular cobblestone pattern. A prospective study included 211 asymptomatic members from 154 NPC families. We found four cases of NPC, all with a tumor stage of T1. In one patient (1/4), MRI revealed a 2-cm-diameter neck lymphadenopathy (N1). The correlation between conventional nasopharyngoscopy and NBI was very high (κ = 0.798, P = 0.000). In conclusions, NBI is not superior to conventional nasopharyngoscopy for the early detection of NPC in unaffected members of families with NPC history. The long-term follow-up is necessary in high-risk NPC patients. Further studies will be needed to determine which screening tool—conventional nasopharyngoscopy, NBI, or EB virus titer—is most effective.Keywords
This publication has 44 references indexed in Scilit:
- Use of narrow band imaging in evaluation of possible nasopharyngeal carcinomaAmerican Journal of Rhinology & Allergy, 2011
- Nasopharyngeal carcinoma risk by histologic type in central China: Impact of smoking, alcohol and family historyInternational Journal of Cancer, 2010
- Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: Experience of 370 consecutive casesBMC Cancer, 2010
- Treatment results and late complications of 556 patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy aloneBritish Journal of Radiology, 2009
- Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screeningFamilial Cancer, 2008
- Dried-Blood Sampling for Epstein-Barr Virus Immunoglobulin G (IgG) and IgA Serology in Nasopharyngeal Carcinoma ScreeningJournal of Clinical Microbiology, 2008
- Single-Assay Combination of Epstein-Barr Virus (EBV) EBNA1- and Viral Capsid Antigen-p18-Derived Synthetic Peptides for Measuring Anti-EBV Immunoglobulin G (IgG) and IgA Antibody Levels in Sera from Nasopharyngeal Carcinoma Patients: Options for Field ScreeningJournal of Clinical Microbiology, 2006
- Is Restoring Platinum Sensitivity the Best Goal for Cetuximab in Recurrent/Metastatic Nasopharyngeal Cancer?Journal of Clinical Oncology, 2005
- Multicenter, Phase II Study of Cetuximab in Combination With Carboplatin in Patients With Recurrent or Metastatic Nasopharyngeal CarcinomaJournal of Clinical Oncology, 2005
- FAMILIAL AGGREGATION IN NASOPHARYNGEAL CARCINOMAThe Lancet, 1974